Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 19.7221.4915.4015.663.98

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 19.72 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202619.72
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 19.72
-8.24
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,877.4 Cr 5.2% 21.8% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.2%

21.8%

5.7%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses